Table 5.
Showing Mortality differences across subgroups of Race, Gender, and Complications.
| Variable | OMVR | TMVR |
|---|---|---|
| Race n (%) | ||
| White | 585 (94.4%) | 35 (5.60%) |
| Black | 65(86.70%) | 10(13.30%) |
| Hispanics | 20(100.00%) | <1% |
| Asian | 30 (100.0%) | <1% |
| Others | 5(50.00%) | 5(50.00%) |
| Gender Differences n (%) | ||
| Male | 345(93.2%) | 25 (6.8%) |
| Female | 380(93.8%) | 25(6.2%) |
| Complications n (%) | ||
| Respiratory failure with hypoxia | 125(17.24%) | <1% |
| Hepatic Failure | 70(9.66%) | <1% |
| AKI | 65(8.97%) | <1% |
| Heart Failure | 60(8.27%) | <1% |
| Cardiogenic Shock | 45(6.20%) | <1% |
| Sepsis | 30 (4%) | <1% |
| Acute post hemorrhagic anemia and DIC | 30(4%) | <1% |
| STEMI | 25(3.4%) | <1% |
| Acute and subacute endocarditis | 20(2.75%) | 20(40%) |
| ESRD | 20(2.75%) | <1% |
| Papillary Muscle rupture | 15(2.06%) | <1% |
| NSTEMI | 10(1.3%) | <1% |